プロテオミクス市場- 世界の産業規模、シェア、動向、機会、予測、製品別、技術別、用途別、タイプ別、エンドユーザー別、地域別セグメント、競合、2020年～2030年

プロテオミクスの世界市場は、2024年に241億1,000万米ドルと評価され、予測期間中のCAGRは11.32%で、2030年には458億7,000万米ドルに達すると予測されています。

プロテオームを大規模に研究するプロテオミクスは、極めて重要な分野です。プロテオミクスは、疾患関連タンパク質の同定やその産生、機能、構造の調査に利用される強力な技術です。がん、感染症、マラリア、結核など、様々な疾患の予後マーカーの発見や診断に重要な役割を果たしています。さらに、製薬分野では、プロテオミクスは薬物の作用や毒性のメカニズムを解明するために広く使用されています。さらに、バイオマーカーの同定と検証にも一般的に応用されています。プロテオームは、生物内のすべてのメッセンジャーRNA分子を含むトランスクリプトームの影響を部分的に受けます。しかし、タンパク質の活性は遺伝子発現レベル以外にも様々な要因の影響を受ける。プロテオミクスの応用範囲は広いです。慢性疾患や感染症の有病率の増加は、プロテオミクス産業の成長を促進します。WHOの予測では、2050年までに新たに発生するがん患者は3,500万人を超え、2022年に推定された約2,000万人から77％も急増します。さらに、疾病の蔓延は、病因の研究や高度な診断・治療薬に対する需要を増大させる。例えば、2024年7月にNature Communications誌に掲載された調査によると、科学者たちはプロテオミクスに基づいたアプローチでリケッチア属が分泌するエフェクターを同定し、宿主と病原体の接点を理解しました。

市場促進要因

がん患者の増加

主な市場課題

高価な器具

主要市場動向

ラベルフリー定量化技術の出現

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のプロテオミクス市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別（試薬・アッセイ、機器、ソフトウェア・サービス）
  • 技術別（分光法、マイクロアレイ装置、クロマトグラフィー、X線結晶構造解析、タンパク質マイクロアレイ、電気泳動）
  • 用途別（臨床診断、創薬、診断バイオマーカー発見、その他）
  • タイプ別（表現、機能、構造、計算）
  • エンドユーザー別（製薬・バイオテクノロジー企業、調査機関、CRO）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 北米のプロテオミクス市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州のプロテオミクス市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域のプロテオミクス市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米のプロテオミクス市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのプロテオミクス市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 世界のプロテオミクス市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• Bruker Corporation
• Promega Corporation
• Agilent Technologies Inc.
• Merck KGaA
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• F Hoffmann-La Roche Ltd.
• Luminex Corporation

第16章 戦略的提言

第17章 調査会社について・免責事項

Global Proteomics Market was valued at USD 24.11 Billion in 2024 and is expected to reach USD 45.87 Billion by 2030 with a CAGR of 11.32% during the forecast period. Proteomics, the study of proteomes on a large scale, is a crucial field. Proteomics is a powerful technique utilized for the identification of disease-associated proteins and the investigation of their production, function, and structure. It plays a crucial role in the discovery of prognostic markers and the diagnosis of various diseases, including cancer, infectious illnesses, malaria, and tuberculosis. Moreover, in the pharmaceutical sector, proteomics is extensively employed to elucidate the mechanisms of drug action and toxicity. Additionally, it is commonly applied in the identification and validation of biomarkers. The proteome is partially influenced by the underlying transcriptome, which encompasses all messenger RNA molecules in an organism. However, protein activity is influenced by various factors beyond gene expression levels. Proteomics has a wide range of applications. The rising prevalence of chronic and infectious diseases drives proteomics industry growth. WHO predicts that there will be over 35 million new cancer cases by 2050, a 77% surge from the approximately 20 million cases estimated in 2022. Moreover, the prevalence of disease increases the demand for pathogenesis research and advanced diagnostics and therapeutics. For instance, according to research published in Nature Communications in July 2024, scientists used a proteomics-based approach to identify effectors secreted by Rickettsia spp, thereby understanding the host-pathogen interface.

Key Market Drivers

Increase In the Number of Patients Suffering from Cancer

The increasing incidence of cancer and other disorders is another crucial factor contributing to the growth of the global proteomics market. With the rising number of cancer cases worldwide, there is a pressing need for effective treatment options. This has resulted in extensive research and development in the field of life sciences, leading to significant advancements and discoveries.

One major breakthrough in this field is the characterization of human proteins, which has revolutionized the field of biomedicine. By studying gene expression at the proteome level, researchers can gain deeper insights into the intricate mechanisms underlying diseases like cancer. This constant research and development in the field of proteomics are anticipated to fuel the market's growth to a great extent. Through the application of proteomics techniques, researchers are able to extract highly significant biological information that greatly enhances our understanding of cancer biology. This knowledge can ultimately benefit patients by improving diagnosis, treatment, and overall patient care.

The continuous advancements in proteomics research not only help in identifying how proteins respond in dynamic environments, such as cancer patients, but also pave the way for the development of personalized medicine. By tailoring treatment plans based on an individual's unique proteomic profile, healthcare providers can maximize the effectiveness of therapies and minimize side effects. The increasing prevalence of cancer, along with the constant progress in proteomics research, holds immense potential for the global proteomics market. The ability to extract valuable insights from the proteome level opens up new opportunities for advancements in diagnosis, treatment, and personalized medicine, ultimately benefiting patients worldwide.

Key Market Challenges

Expensive Instruments

The need for a longer period of time in laboratories increases the cost of treatment. This is primarily due to the expensive instruments and reagents used in the process, which limits the use of this technology in developing nations. One of the most commonly used methods in proteomics is X-ray crystallography. This method involves protein expression, gene cloning, protein crystallization, and purification. However, these procedures are time-consuming, resulting in higher costs. As a result, the adoption of these procedures in developing nations is limited. This presents a significant challenge to the growth of the market and will continue to hinder its progress in the long run.

To overcome this obstacle and promote market growth in developing nations, it is crucial to expand the accessibility and affordability of these technologies. By doing so, more laboratories and research institutions in these regions will be able to utilize these advanced techniques to study proteins and contribute to scientific advancements. This, in turn, can lead to improved healthcare solutions, better understanding of diseases, and the development of targeted therapies.

Furthermore, addressing the cost issue can also encourage collaborations between developed and developing nations in the field of proteomics. By sharing resources, knowledge, and expertise, it becomes possible to overcome the financial limitations and accelerate the progress of research and innovation. This collaborative approach can create a more inclusive and globally connected scientific community, where breakthroughs in proteomics are not limited by economic constraints.

The longer time required and higher costs associated with proteomic research in laboratories pose challenges to its widespread adoption in developing nations. However, by expanding the accessibility, affordability, and fostering international collaborations, we can overcome these obstacles and promote market growth in these regions. This will not only advance scientific knowledge but also contribute to improving healthcare outcomes for people around the world.

Key Market Trends

Emergence Of Label-Free Quantification Techniques

The emergence of label-free quantification techniques is a major trend in the market. The global proteomics market has witnessed notable trends, including the rise of label-free quantification techniques. Label-free quantification, a revolutionary approach in proteomics, utilizes mass spectrometry-based methods to accurately measure proteins without the need for chemical or isotopic labels. By eliminating the use of labels, this technique offers enhanced accuracy, reproducibility, and cost-effectiveness, making it an attractive option for researchers. Moreover, label-free quantification enables the analysis of larger sample sizes, allowing for more comprehensive proteomic studies. Additionally, this approach avoids potential artifacts that may arise from labeling interference, ensuring the integrity of the protein quantification results. As the demand for high-throughput, reliable, and cost-effective proteomic analysis continues to grow, the adoption of label-free quantification techniques is expected to increase rapidly in the coming years, revolutionizing the field of proteomics and advancing our understanding of complex biological systems.

Key Market Players

• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• Bruker Corporation
• Promega Corporation
• Agilent Technologies Inc.
• Merck KGaA
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• F Hoffmann-La Roche Ltd.
• Luminex Corporation

Report Scope:

In this report, the Global Proteomics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Proteomics Market, By Product:

• Reagents & Assays
• Instruments
• Software & Services

Proteomics Market, By Technology:

• Spectroscopy
• Microarray instruments
• Chromatography
• X-ray crystallography
• Protein Microarrays
• Electrophoresis

Proteomics Market, By Application:

• Clinical Diagnostic
• Drug Discovery
• Diagnostic Biomarker Discovery
• Others

Proteomics Market, By Type:

• Expression
• Functional
• Structural
• Computational

Proteomics Market, By End User:

• Pharmaceutical and Biotechnology Companies
• Research Institutes
• CROs

Proteomics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Proteomics Market.

Available Customizations:

Global Proteomics market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Proteomics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Reagents and Assays, Instruments, Software & Services)
  • 5.2.2. By Technology (Spectroscopy, Microarray instruments, Chromatography, X-ray crystallography, Protein Microarrays, Electrophoresis)
  • 5.2.3. By Application (Clinical Diagnostic, Drug Discovery, Diagnostic Biomarker Discovery, Others)
  • 5.2.4. By Type (Expression, Functional, Structural, Computational)
  • 5.2.5. By End User (Pharmaceutical and Biotechnology Companies, Research Institutes, CROs)
  • 5.2.6. By Region
  • 5.2.7. By Company (2024)
• 5.3. Market Map

6. North America Proteomics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Technology
  • 6.2.3. By Application
  • 6.2.4. By Type
  • 6.2.5. By End User
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Proteomics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By Type
      • 6.3.1.2.5. By End User
  • 6.3.2. Canada Proteomics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By Type
      • 6.3.2.2.5. By End User
  • 6.3.3. Mexico Proteomics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By Type
      • 6.3.3.2.5. By End User

7. Europe Proteomics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Technology
  • 7.2.3. By Application
  • 7.2.4. By Type
  • 7.2.5. By End User
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Proteomics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By Type
      • 7.3.1.2.5. By End User
  • 7.3.2. United Kingdom Proteomics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By Type
      • 7.3.2.2.5. By End User
  • 7.3.3. Italy Proteomics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By Type
      • 7.3.3.2.5. By End User
  • 7.3.4. France Proteomics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By Type
      • 7.3.4.2.5. By End User
  • 7.3.5. Spain Proteomics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By Type
      • 7.3.5.2.5. By End User

8. Asia-Pacific Proteomics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Technology
  • 8.2.3. By Application
  • 8.2.4. By Type
  • 8.2.5. By End User
  • 8.2.6. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Proteomics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By Type
      • 8.3.1.2.5. By End User
  • 8.3.2. India Proteomics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By Type
      • 8.3.2.2.5. By End User
  • 8.3.3. Japan Proteomics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By Type
      • 8.3.3.2.5. By End User
  • 8.3.4. South Korea Proteomics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By Type
      • 8.3.4.2.5. By End User
  • 8.3.5. Australia Proteomics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By Type
      • 8.3.5.2.5. By End User

9. South America Proteomics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Technology
  • 9.2.3. By Application
  • 9.2.4. By Type
  • 9.2.5. By End User
  • 9.2.6. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Proteomics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By Type
      • 9.3.1.2.5. By End User
  • 9.3.2. Argentina Proteomics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By Type
      • 9.3.2.2.5. By End User
  • 9.3.3. Colombia Proteomics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By Type
      • 9.3.3.2.5. By End User

10. Middle East and Africa Proteomics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Technology
  • 10.2.3. By Application
  • 10.2.4. By Type
  • 10.2.5. By End User
  • 10.2.6. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Proteomics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By Type
      • 10.3.1.2.5. By End User
  • 10.3.2. Saudi Arabia Proteomics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By Type
      • 10.3.2.2.5. By End User
  • 10.3.3. UAE Proteomics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By Type
      • 10.3.3.2.5. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Proteomics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Illumina, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Thermo Fisher Scientific Inc.
• 15.3. Bruker Corporation
• 15.4. Promega Corporation
• 15.5. Agilent Technologies Inc.
• 15.6. Merck KGaA
• 15.7. Bio-Rad Laboratories, Inc.
• 15.8. Danaher Corporation
• 15.9. F Hoffmann-La Roche Ltd.
• 15.10. Luminex Corporation

16. Strategic Recommendations

17. About Us & Disclaimer